Rebecca Lee
Dermatology · Little Rock, ARNPI 1417340589
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,460 of the $3,878 with a category attached, or 89.2%. It is spread thinly across 22 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,143 and has fallen 77.4% since, to $259 in 2025. That places this record below the midpoint for dermatology clinicians in AR, where the typical reported total is $3,769.
Across 138 payments — averaging $28.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$725
- Lilly USA, LLC$666
- AbbVie$430
- Johnson & Johnson$416
- Pfizer$356
- Sun Pharmaceutical Industries Inc.$288
- plus $997 from 16 others
What the payments were for
- Food & beverage$3,46089%
- Education$41811%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 27 | $725 |
| Lilly USA, LLC | 33 | $666 |
| AbbVie | 19 | $430 |
| Johnson & Johnson | 10 | $416 |
| Pfizer | 14 | $356 |
| Sun Pharmaceutical Industries Inc. | 7 | $288 |
| Novartis | 8 | $196 |
| Regeneron Healthcare Solutions, Inc. | 2 | $158 |
| Sanofi | 3 | $154 |
| Kyowa Kirin, Inc. | 1 | $108 |
| Dermavant Sciences, Inc. | 1 | $89 |
| Organogenesis Inc. | 1 | $61 |
| Amgen | 2 | $39 |
| Dermira, Inc. | 2 | $36 |
| Madrigal Pharmaceuticals | 1 | $26 |
| Genentech USA, Inc. | 1 | $25 |
| Incyte Corporation | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
| LEO Pharma Inc. | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
| Boehringer Ingelheim | 1 | $14 |
| Galderma Laboratories, L.p. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,878 in reported general payments places this provider in the 50th percentile of 75 dermatology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Taltz AutoinjectorIxekizumab | 14 | $100,048 |
| Ketoconazole | 143 | $2,257 |
| Clobetasol Propionate | 30 | $1,823 |
| Desonide | 13 | $899 |
| Betamethasone Dipropionate | 20 | $700 |
| Triamcinolone Acetonide | 51 | $529 |
| Doxycycline Hyclate | 14 | $186 |
| Nystatin | 21 | $177 |
| Mupirocin | 19 | $153 |
| Fluconazole | 12 | $110 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Little Rock
- Brian WayneLittle Rock$13K
- Andrea MabryLittle Rock$12K
- Thomas ManningLittle Rock$11K
- Marla WirgesLittle Rock$11K
- Kayla MohrLittle Rock$9K
- Gregory DwyerLittle Rock$8K
- Gunnar GibsonLittle Rock$7K
- Garrett NelsonLittle Rock$6K
- Jacey GuthrieLittle Rock$6K
- Lindsay LipkeLittle Rock$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.